A cost-utility analysis of cochlear implants for single sided deafness in adults and children in the Netherlands.

Chris van LieshoutKatharina AbrahamAdriana Leni SmitGeert W J Frederix

Published in: PloS one (2024)

Based on the results of this health economic evaluation with a Markov cohort model, it is very likely that CI is cost-effective compared to BCD and to no treatment in the Dutch adult and pediatric population with SSD. In both populations the ICER was below the Dutch cost-effectiveness threshold of €20,000/QALY.

Keyphrases

healthcare
public health
mental health
health information
risk assessment